AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,580 | +3.7% | 18,275 | +5.9% | 0.00% | – |
| Q2 2023 | $41,055 | +31.8% | 17,250 | +1.9% | 0.00% | – |
| Q1 2023 | $31,142 | -3.2% | 16,925 | 0.0% | 0.00% | – |
| Q4 2022 | $32,158 | +3115.8% | 16,925 | +3285.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | – | 500 | +900.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 50 | -50.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -97.1% | 100 | -98.3% | 0.00% | – |
| Q1 2021 | $34,000 | -26.1% | 5,850 | +14.7% | 0.00% | – |
| Q4 2020 | $46,000 | -20.7% | 5,100 | +2.0% | 0.00% | – |
| Q3 2020 | $58,000 | -51.7% | 5,000 | -33.3% | 0.00% | – |
| Q2 2020 | $120,000 | +160.9% | 7,500 | -8.5% | 0.00% | – |
| Q1 2020 | $46,000 | – | 8,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,530,657 | $23,126,000 | 1.85% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,375,000 | 1.00% |
| Nantahala Capital Management | 2,936,791 | $19,236,000 | 0.61% |
| MYDA Advisors LLC | 171,953 | $1,126,000 | 0.32% |
| SABBY MANAGEMENT, LLC | 300,000 | $1,965,000 | 0.27% |
| Regency Capital Management Inc.\DE | 57,000 | $373,000 | 0.26% |
| Ikarian Capital, LLC | 544,819 | $3,568,000 | 0.25% |
| Eversept Partners, LP | 398,074 | $2,607,385 | 0.18% |
| Henry James International Management Inc. | 54,047 | $354,000 | 0.11% |
| Alphabet Inc. | 698,262 | $4,574,000 | 0.11% |